What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Parkinson's disease
- Dopamine
Parkinson's disease, Dopamine, Internal medicine, Endocrinology and Central nervous system disease are his primary areas of study.
His studies in Parkinson's disease integrate themes in fields like Neuroscience and Parkinsonism.
The concepts of his Parkinsonism study are interwoven with issues in Mutation and Missense mutation.
A. Jon Stoessl combines topics linked to Neurotransmitter with his work on Dopamine.
His research in Internal medicine is mostly concerned with Disease.
A. Jon Stoessl combines subjects such as Catecholamine and Dopamine agonist with his study of Central nervous system disease.
His most cited work include:
- Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology (2198 citations)
- A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease† (1226 citations)
- Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. (804 citations)
What are the main themes of his work throughout his whole career to date?
A. Jon Stoessl mainly focuses on Parkinson's disease, Dopamine, Internal medicine, Neuroscience and Endocrinology.
His research investigates the connection with Parkinson's disease and areas like Central nervous system disease which intersect with concerns in Transplantation and Urology.
A. Jon Stoessl studied Dopamine and Levodopa that intersect with Catecholamine.
His Internal medicine research includes themes of Methylphenidate and Oncology.
His research investigates the connection between Endocrinology and topics such as Agonist that intersect with issues in Tachykinin receptor.
His Parkinsonism study integrates concerns from other disciplines, such as Genetics, Dementia and Missense mutation.
He most often published in these fields:
- Parkinson's disease (48.23%)
- Dopamine (37.61%)
- Internal medicine (35.84%)
What were the highlights of his more recent work (between 2017-2021)?
- Parkinson's disease (48.23%)
- Disease (21.24%)
- Dopamine (37.61%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Parkinson's disease, Disease, Dopamine, Dopaminergic and Internal medicine.
He works mostly in the field of Parkinson's disease, limiting it down to topics relating to Glial cell line-derived neurotrophic factor and, in certain cases, Anesthesia, Unified Parkinson's disease rating scale, Randomization and Clinical endpoint.
While the research belongs to areas of Disease, he spends his time largely on the problem of Intensive care medicine, intersecting his research to questions surrounding Neurology, Therapeutic strategy, Dyskinesia and Levodopa therapy.
Dopamine is often connected to Levodopa in his work.
His Internal medicine research incorporates themes from White matter, Endocrinology, Lesion, Oncology and Cardiology.
His Endocrinology study combines topics from a wide range of disciplines, such as Serotonergic and LRRK2.
Between 2017 and 2021, his most popular works were:
- Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease (95 citations)
- Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease. (56 citations)
- Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease : a multi-country Delphi-panel approach (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Parkinson's disease
- Disease
A. Jon Stoessl mainly investigates Parkinson's disease, Disease, Dopamine, Neuroscience and Striatum.
The Parkinson's disease study combines topics in areas such as Glial cell line-derived neurotrophic factor and Urology.
His Disease research is multidisciplinary, incorporating perspectives in Biomarker, Clinical trial and Intensive care medicine.
Internal medicine and Endocrinology are the areas that his Dopamine study falls under.
His work in the fields of Internal medicine, such as LRRK2 and Cholinergic, overlaps with other areas such as Acetylcholinesterase.
His research investigates the connection between Striatum and topics such as Dopaminergic that intersect with problems in Neurodegeneration and Movement disorders.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
